Botulinum toxin treatment for upper airway collapse resulting from temporomandibular joint dislocation due to jaw-opening dystonia

Cranio - Journal of Craniomandibular and Sleep Practice

Volumn 24, Issue 3, 2006, Pages 217-222

  Yoshida, Kazuya ^a   Iizuka, Tadahiko ^b  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33746898613     PISSN: 08869634     EISSN: None     Source Type: Journal    
DOI: 10.1179/crn.2006.035     Document Type: Article

References (22)

1. Yoshida K: Prosthetic therapy for sleep apnea syndrome. J Prosthet Dent 1994; 72:296-302.
2. Yoshida K: Effects of a mandibular advancement device for the treatment of sleep apnea syndrome and snoring on respiratory function and sleep quality. J Craniomandib Pract 2000; 18:98-105.
3. Yoshida K: Influence of sleep posture on response to oral appliance therapy for sleep apnea syndrome. Sleep 2001; 24:538-544.
4. Fahn S: Concept and classification of dystonia. Adv Neurol 1988; 50:1-8.
5. Blitzer A, Brin M, Greene PE, Fahn S: Botulinum toxin injection for the treatment of oromandibular dystonia. Ann Otol Rhinol Laryngol 1989; 98:93-97.
6. Yoshida K, Kaji R, Kubori T, Kohara N, Iizuka T, Kimura J: Muscle afferent block for the treatment of oromandibular dystonia. Mov Disord 1998; 13:699-705.
7. Yoshida K, Kaji R, Shibasaki H, Iizuka T: Factors influencing the therapeutic effect of muscle afferent block for oromandibular dystonia and dyskinesia: implications for their distinct pathophysiology. Int J Oral Maxillofac Surg 2002; 31:499-505.
8. Yoshida K. Kaji R, Takagi A, Iizuka T: Customized EMG needle insertion guide for the muscle afferent block of jaw-deviation and jaw-opening dystonias. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 88:664-669.
9. Jankovic J, Brin MF: Therapeutic uses of botulinum toxin. New Engl J Med 1991; 324:1186-1194.
10. Jankovic J, Schwartz K, Donovan DT: Botulinum treatment of cranio-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry 1990; 53:633-639.
11. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology: Assessment: the clinical usefulness of botulinum toxin-A in treating neurologic disorders. Neurol 1990; 40:1332-1336.
12. Tan EK, Jankovic J: Botulinum toxin A in patients with oromandibular dystonia long-term follow-up. Neurol 1999; 53:2102-2107.
13. Moore AP, Wood GD: Medical treatment of recurrent temporomandibular joint dislocation using botulinum toxin A. Br Dent J 1997; 183:415-417.
14. Roser M, Cornelius CP, Topka H: Neuerungen in der MKG-Chirurgie: Lokale Injektionsbehandlung mit Botulinumtoxin A. Mund Kiefer GesichtsChir 1998; [supl 2]:121-124.
15. Daelen B, Koch A, Thorwirth V: Botulinumtoxinbehandlung der neurogene Kiefergelenkluxation. Mund Kiefer GesichtsChir 1998; [supl] 2:125-129.
16. Umstadt HE: Botulinumtoxin in der MKG-Chirurgie. Mund Kiefer GesichtsChir 2002; 6:249-260.
17. Ziegler CM, Haag C, Mühling J: Treatment of recurrent temporomandibular joint dislocation with intramuscular botulinum toxin injection. Clin Oral Invest 2003; 7:52-55.
18. Kaji R, et al.: Tonic vibration reflex and muscle afferent block in writer's cramp. Ann Neurol 1995; 38:155-162.
19. Penn RD, Savoy SM, Corcos D, Latash M, Gottlieb G, Parke B, Kroin JS: Intrathecal baclofen for severe spinal spasticity. N Engl J Med 1989; 320:1517-1521.
20. Yoshida K: Masticatory muscle responses associated with unloading of biting force during food crushing. J Oral Rehabil 1998; 25:830-837.
21. Yoshida K: Muskelafferenzblockierung in der Behandlung der oromandibularen Dystonie Unterschiedliche Wirkung auf Kau- und Zungenmuskulatur. Nervenarzt 2003; 74:516-522.
22. Yoshida K, Sakamoto K, Takagi A, Iizuka T: Three-piece oral appliance with Herbst attachments for persistent vegetative state patient with sleep-disordered breathing. Int J Prosthodont 2003; 16:350-354.